search
Back to results

The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients

Primary Purpose

Leprosy

Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Routine treatment
Low level laser therapy (LLLT)
Sponsored by
Para Federal University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Leprosy focused on measuring Leprosy, Ulcers, Laser

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • presented with neuropathic ulcer
  • attended at least 3 weekly appointments at the dressing service of UREMC
  • completed specific multi-drug therapy for M. leprae
  • gave written informed consent to participate in the study

Exclusion Criteria:

  • clinically detectable infection in the ulcer
  • use of drugs, like corticosteroids that could interfere with the wound healing process
  • use of special dressings like hydrocolloid, calcium alginate, activated carbon or any kind of therapeutic procedure different from that used routinely for both groups of study
  • non-attendance to therapeutic program (six sequential times or nine intercalated)
  • pregnancy
  • discomfort during treatment procedure

Sites / Locations

  • Dr. Marcello Candia Reference Unit in Sanitary Dermatology of the State of Pará in Brazil (UREMC)

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

1

2

Arm Description

Subjects from the arm number 1 received routine treatment, including daily simple dressings with sterile gauze after wound cleaning with a 0.9% physiologic solution, use of 1% hydrophilic silver sulfadiazine cream (Prati Donaduzzi Laboratory, Toledo, Brazil) and orientation about the use of adapted footwear, self-care and the prevention of disabilities. Surgical debridement was done whenever indicated by nursing or orthopedic services from UREMC.

Subjects from the arm number 2 received low level laser therapy 3 times per week for 12 weeks, in addition to the same treatment as patients from the arm number 1.

Outcomes

Primary Outcome Measures

Wound healing

Secondary Outcome Measures

Ulcer surface area, depth and PUSH tool score.

Full Information

First Posted
March 11, 2009
Last Updated
December 12, 2009
Sponsor
Para Federal University
search

1. Study Identification

Unique Protocol Identification Number
NCT00860717
Brief Title
The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients
Official Title
Clinic-Epidemiological Evaluation of Ulcers in Leprosy Patients and the Use of Low Level Laser Therapy: a Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2009
Overall Recruitment Status
Completed
Study Start Date
November 2006 (undefined)
Primary Completion Date
January 2008 (Actual)
Study Completion Date
April 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Para Federal University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Neuropathic ulcers are common sequelae of leprosy. The objectives of this study are to analyze the clinic-epidemiological characteristics of patients attended at one specialized dressing service from a leprosy-endemic region of the Brazilian Amazon and to evaluate the effect of Low Level Laser Therapy on wound healing of these patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Leprosy
Keywords
Leprosy, Ulcers, Laser

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
25 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
Subjects from the arm number 1 received routine treatment, including daily simple dressings with sterile gauze after wound cleaning with a 0.9% physiologic solution, use of 1% hydrophilic silver sulfadiazine cream (Prati Donaduzzi Laboratory, Toledo, Brazil) and orientation about the use of adapted footwear, self-care and the prevention of disabilities. Surgical debridement was done whenever indicated by nursing or orthopedic services from UREMC.
Arm Title
2
Arm Type
Experimental
Arm Description
Subjects from the arm number 2 received low level laser therapy 3 times per week for 12 weeks, in addition to the same treatment as patients from the arm number 1.
Intervention Type
Procedure
Intervention Name(s)
Routine treatment
Intervention Description
Subjects from the Control Group received routine treatment, including daily simple dressings with sterile gauze after wound cleaning with a 0.9% physiologic solution, use of 1% hydrophilic silver sulfadiazine cream (Prati Donaduzzi Laboratory, Toledo, Brazil) and orientation about the use of adapted footwear, self-care and the prevention of disabilities. Surgical debridement was done whenever indicated by nursing or orthopedic services from UREMC.
Intervention Type
Radiation
Intervention Name(s)
Low level laser therapy (LLLT)
Other Intervention Name(s)
LLLT, Cold laser, LILT
Intervention Description
The LLLT equipment was an indium-gallium-aluminnium-phosphide (InGaAlP) semiconductor laser with a maximum output power of 40 mW, continuous radiation emission of visible red light with 660 nm wavelength (+/- 10 nm) and a spot area of 0.04 cm². The energy density used was 4 J per point in the wound edges and 2 J/cm² in the wound bed with a power density of 1 W/cm2. Wound beds were irradiated using a scanning technique with no direct contact.
Primary Outcome Measure Information:
Title
Wound healing
Time Frame
Biweekly until the end of the 12 week treatment period.
Secondary Outcome Measure Information:
Title
Ulcer surface area, depth and PUSH tool score.
Time Frame
Biweekly until the end of the 12 week treatment period or until complete cicatrization of the treated ulcer.

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: presented with neuropathic ulcer attended at least 3 weekly appointments at the dressing service of UREMC completed specific multi-drug therapy for M. leprae gave written informed consent to participate in the study Exclusion Criteria: clinically detectable infection in the ulcer use of drugs, like corticosteroids that could interfere with the wound healing process use of special dressings like hydrocolloid, calcium alginate, activated carbon or any kind of therapeutic procedure different from that used routinely for both groups of study non-attendance to therapeutic program (six sequential times or nine intercalated) pregnancy discomfort during treatment procedure
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Claudio G Salgado, Dr
Organizational Affiliation
Federal University of Pará
Official's Role
Study Director
Facility Information:
Facility Name
Dr. Marcello Candia Reference Unit in Sanitary Dermatology of the State of Pará in Brazil (UREMC)
City
Marituba
State/Province
Pará
ZIP/Postal Code
67200-000
Country
Brazil

12. IPD Sharing Statement

Citations:
PubMed Identifier
10796615
Citation
Flemming K, Cullum N. Laser therapy for venous leg ulcers. Cochrane Database Syst Rev. 2000;(2):CD001182. doi: 10.1002/14651858.CD001182.
Results Reference
background
PubMed Identifier
15496990
Citation
Hopkins JT, McLoda TA, Seegmiller JG, David Baxter G. Low-Level Laser Therapy Facilitates Superficial Wound Healing in Humans: A Triple-Blind, Sham-Controlled Study. J Athl Train. 2004 Sep;39(3):223-229.
Results Reference
background
PubMed Identifier
10721863
Citation
Schindl A, Schindl M, Pernerstorfer-Schon H, Mossbacher U, Schindl L. Low intensity laser irradiation in the treatment of recalcitrant radiation ulcers in patients with breast cancer--long-term results of 3 cases. Photodermatol Photoimmunol Photomed. 2000 Feb;16(1):34-7. doi: 10.1034/j.1600-0781.2000.160109.x.
Results Reference
background
PubMed Identifier
12928815
Citation
Lucas C, van Gemert MJ, de Haan RJ. Efficacy of low-level laser therapy in the management of stage III decubitus ulcers: a prospective, observer-blinded multicentre randomised clinical trial. Lasers Med Sci. 2003;18(2):72-7. doi: 10.1007/s10103-003-0259-5.
Results Reference
background
PubMed Identifier
12376047
Citation
Franek A, Krol P, Kucharzewski M. Does low output laser stimulation enhance the healing of crural ulceration? Some critical remarks. Med Eng Phys. 2002 Nov;24(9):607-15. doi: 10.1016/s1350-4533(02)00112-1.
Results Reference
background
PubMed Identifier
11169174
Citation
Schubert V. Effects of phototherapy on pressure ulcer healing in elderly patients after a falling trauma. A prospective, randomized, controlled study. Photodermatol Photoimmunol Photomed. 2001 Feb;17(1):32-8. doi: 10.1034/j.1600-0781.2001.017001032.x.
Results Reference
background
PubMed Identifier
12355572
Citation
Pereira AN, Eduardo Cde P, Matson E, Marques MM. Effect of low-power laser irradiation on cell growth and procollagen synthesis of cultured fibroblasts. Lasers Surg Med. 2002;31(4):263-7. doi: 10.1002/lsm.10107.
Results Reference
background
PubMed Identifier
20698989
Citation
Barreto JG, Salgado CG. Clinic-epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. BMC Infect Dis. 2010 Aug 10;10:237. doi: 10.1186/1471-2334-10-237.
Results Reference
derived

Learn more about this trial

The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients

We'll reach out to this number within 24 hrs